Current prevalence of multidrug-resistant organisms in long-term care facilities in the Rhine-Main district, Germany,

M Hogardt1, P Proba, D Mischler

  • 1Institute for Medical Microbiology and Infection Control, University Hospital, Goethe-University, Frankfurt am Main, Germany.

Insights

Multidrug-resistant Gram-negative organisms (MRGN) carriage is remarkably high in German long-term care facilities, with rates significantly increasing. Meticillin-resistant Staphylococcus aureus (MRSA) prevalence remained stable, but unknown MDRO carriage highlights screening gaps.

Area of Science:

  • Infectious Diseases
  • Healthcare Epidemiology
  • Microbiology

Background:

  • Multidrug-resistant organisms (MDRO), especially multidrug-resistant Gram-negative organisms (MRGN), pose a growing challenge in healthcare settings.
  • Data on MDRO prevalence in long-term care facilities (LTCFs) are scarce, necessitating current prevalence assessments.

Purpose of the Study:

  • To determine the prevalence of MDRO, including meticillin-resistant Staphylococcus aureus (MRSA), MRGN, and vancomycin-resistant enterococci (VRE), among residents in German LTCFs.
  • To identify risk factors associated with MDRO carriage in this population.

Main Methods:

  • A point prevalence survey was conducted in 2013 across 26 LTCFs in the German Rhine-Main region.
  • Swabs (nose, throat, perineum) were analyzed for MRSA, and perianal swabs for ESBL-producing organisms, MRGN, and VRE.
  • Data were collected from 690 residents for MRSA and 455 for rectal carriage of ESBL/MRGN and VRE.

Main Results:

  • Prevalence rates were 6.5% for MRSA, 17.8% for ESBL/MRGN, and 0.4% for VRE.
  • MRSA carriage was linked to prior MRSA infection, urinary catheters, feeding tubes, and antibiotic use.
  • ESBL/MRGN carriage was exclusively associated with the presence of urinary catheters.

Conclusions:

  • MRSA prevalence in German LTCFs has not increased since 2007.
  • The prevalence of ESBL/MRGN carriage in LTCFs is notably high, with most cases previously undiagnosed.
  • This highlights potential deficits in screening protocols and communication of patient status upon hospital discharge.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
43
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
115
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
38
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.0K